Los Angeles Capital Management LLC Sells 3,952 Shares of Encompass Health Corporation $EHC

Los Angeles Capital Management LLC cut its holdings in Encompass Health Corporation (NYSE:EHC) by 9.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 37,329 shares of the company’s stock after selling 3,952 shares during the period. Los Angeles Capital Management LLC’s holdings in Encompass Health were worth $4,578,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Invesco Ltd. increased its holdings in shares of Encompass Health by 5.1% during the first quarter. Invesco Ltd. now owns 5,818,783 shares of the company’s stock worth $589,326,000 after purchasing an additional 282,532 shares during the period. T. Rowe Price Investment Management Inc. raised its holdings in Encompass Health by 25.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock valued at $210,756,000 after acquiring an additional 424,691 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Encompass Health by 5.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,871,581 shares of the company’s stock valued at $189,549,000 after acquiring an additional 93,992 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Encompass Health by 13.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,822,376 shares of the company’s stock worth $184,571,000 after purchasing an additional 211,707 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. increased its position in shares of Encompass Health by 11.9% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,541,477 shares of the company’s stock worth $156,121,000 after purchasing an additional 163,400 shares during the period. Institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on EHC. UBS Group upped their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Zacks Research raised Encompass Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 21st. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Finally, Bank of America boosted their target price on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Three investment analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $142.86.

Insider Activity at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the sale, the executive vice president owned 18,846 shares of the company’s stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 2.00% of the company’s stock.

Encompass Health Price Performance

Encompass Health stock opened at $115.18 on Monday. The stock has a 50-day moving average price of $123.54 and a two-hundred day moving average price of $119.64. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $127.99. The company has a market capitalization of $11.59 billion, a PE ratio of 21.77, a P/E/G ratio of 2.20 and a beta of 0.91. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The company had revenue of $136.30 million for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a dividend of $0.19 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 14.37%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.